Find your path to Michèle
Sign up to see every warm intro you have to Michèle
- Paths you didn't know you had: your email and LinkedIn already hold routes to Michèle. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Co-founder and Senior Advisor at Medicxi who previously spent a decade as a Partner at Index Ventures and earlier served as Investment Director at Edmond de Rothschild Investment Partners in Paris. She has led numerous biopharma investments and spent over 15 years in development and marketing roles across Sanofi, BMS, Aventis and Serono, and holds a medical degree.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Investments
Led
AegerionKaerus BiosciencesMinerva NeurosciencesOncoEthixPalladio BiosciencesPearl River BioVillaris Therapeutics
Board seats
Alys PharmaceuticalsIpsen Pharmaceuticals
Per the firm's website.
Colleagues at Medicxi
Frequently asked questions
- Who is Michèle Ollier?
- Co-founder and Senior Advisor at Medicxi who previously spent a decade as a Partner at Index Ventures and earlier served as Investment Director at Edmond de Rothschild Investment Partners in Paris. She has led numerous biopharma investments and spent over 15 years in development and marketing roles across Sanofi, BMS, Aventis and Serono, and holds a medical degree.
- Where does Michèle Ollier work?
- Michèle Ollier is Co-founder & Senior Advisor at Medicxi.
- What does Michèle Ollier invest in?
- Michèle Ollier invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Michèle Ollier sit on?
- Michèle Ollier holds tracked board seats at Alys Pharmaceuticals, Ipsen Pharmaceuticals.
- What companies has Michèle Ollier invested in?
- Investments tracked here include Aegerion, Kaerus Biosciences, Minerva Neurosciences, OncoEthix, Palladio Biosciences, Pearl River Bio, Villaris Therapeutics.
- Does Michèle Ollier lead rounds?
- Yes — Michèle Ollier has led 7 tracked investments.
About this profile. Compiled from public sources — Medicxi's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights







